Kleerekoper et al. reported that increased aromatization of androgen to estrogens in adipose tissue, lowered sex hormone binding globulin levels with increased free sex steroids, and bone formation induced by increased levels of circulating insulin in obesity may clarify the effects exerted by adipose tissue in the genesis of osteoporosis [ 20].
Since sex-hormone binding globulin levels increase nearly 2-fold over the male lifespan, bioavailable T is markedly decreased by aging [ 136, 137].
Kasper et al. found that both testosterone and sex hormone-binding globulin levels increased significantly with increasing diabetes duration (p = 0.02 and 0.002, respectively) 49.
An excess of fat mass is associated with an increased secretion of insulin and amylin from pancreatic β-cells, decreased sex hormone binding globulin serum levels with increased levels of free sex steroids, and changes in the production of adipokines, among the more studied being leptin and adiponectin.
Hyperinsulinemia is also associated with decreased plasma levels of sex hormone binding globulin, leading to increases in free (unbound) testosterone and estradiol, and the aromatization of excess androgen to estrogen in adipose tissue may also increase estrogen levels [ 38].
We compared the association of follicle-stimulating hormone (FSH) and sex hormone binding globulin (SHBG) with metabolic syndrome (MetS).
Obesity is also associated with significant hormonal changes such as decreased serum estradiol and sex hormone binding globulin (SHBG) levels, increased peripheral fat conversion of estrogens to progesterone and increased serum testosterone levels that may be associated with an increased risk of breast cancer [ 17].
We were also interested in exploring the interaction with diabetes mellitus as insulin resistance can lead to increased levels of plasma insulin, lower levels of plasma sex hormone binding globulin and, consequently, increased levels of free estrogen [ 34].
52 Circulating testosterone is highly bound to sex hormone binding globulin (SHBG) and as SHBG increases with age, the total amount of bioavailable testosterone decreases.
In breast cancer, insulin induces aromatase activity and reduces sex hormone binding globulin (SHBG), leading to increased free oestrogen levels, which in turn increases mitogenicity [ 39].
